Cargando…
Personalise vitamin D(3) using physiologically based pharmacokinetic modelling
Plasma concentration of vitamin D(3) metabolite 25‐hydroxyvitamin D(3) (25(OH)D(3)) is variable among individuals. The objective of this study is to establish an accurate model for 25(OH)D(3) pharmacokinetics (PKs) to support selection of a suitable dose regimen for an individual. We collated vitami...
Autores principales: | Huang, Zhonghui, You, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302240/ https://www.ncbi.nlm.nih.gov/pubmed/33960722 http://dx.doi.org/10.1002/psp4.12640 |
Ejemplares similares
-
Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
por: Yellepeddi, Venkata K., et al.
Publicado: (2020) -
Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
por: Yang, Xiaoxia, et al.
Publicado: (2015) -
Evaluation of drug–drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
por: Ji, Tao, et al.
Publicado: (2022) -
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
por: Berton, Mattia, et al.
Publicado: (2022) -
Human physiologically based pharmacokinetic model for propofol
por: Levitt, David G, et al.
Publicado: (2005)